This presentation provides an overview of the hepatitis C virus monitoring program implemented for state Medicaid to contain costs and to promote optimal member care. Key clinical and economic outcomes of the monitoring program are highlighted and formulary management strategies for novel hepatitis C virus agents identified.
One State's Perspective on the Management of Hepatitis C Drugs
Friday, February 27, 2015
American Drug Utilization Review Society 2015